The PharmaTox Strategic Research Initiative aims to generate novel insight on effects of pharmaceuticals on human neurotoxicity and neurodevelopment.
PharmaTox was established January 1st 2015 as a prioritized research initiative supported by the Faculty of Mathematics and Natural Sciences.
The research projects within PharmaTox involve specialists in neurotoxicology, pharmacology, teratology, statistics, bioinformatics, epigenetics and epidemiology.
UiOLifeScience supports internalization for two PharmaTox researchers!
Sep. 17, 2018 10:02 AM
Life sciences represent the largest priority area of the University of Oslo (UiO) and aim to support multidisciplinary collaboration and research mobility. Dr. Angela Lupattelli and PhD student Anna S. Frank in PharmaTox have both been granted funding by UiOLifeScience to support international project collaborations.
PharmaTox researchers at ICPE in Prague
Sep. 10, 2018 12:59 PM
Several PharmaTox researchers attended the 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management August 22-26 in Prague which was organized by the International Society of PharmacoEpidemiology (ISPE).
PharmaTox Skill-swap session
Sep. 10, 2018 12:47 PM
Read about the first PharmaTox Skill-swap event hosted by the Neurobiology and Toxicology laboratory.
Research stay at Cornell University
Aug. 7, 2018 9:38 AM
PhD student Anna Frank was a Visiting Fellow at the Department of Biological Statistics and Computational Biology, Cornell University, New York, USA earlier this year. Read more about her stay.
Article published in Horizon magazine
July 30, 2018 10:51 AM
PharmaTox's research is being noticed in the EU! Horizon magazine recently published the article "Finding drugs that are safe to take while pregnant".